Recap: Fennec Pharmaceuticals Q1 Earnings

Comments
Loading...

Fennec Pharmaceuticals FENC reported its Q1 earnings results on Thursday, May 11, 2023 at 06:01 AM.

Here's what investors need to know about the announcement.

Earnings

Fennec Pharmaceuticals missed estimated earnings by 9.52%, reporting an EPS of $-0.23 versus an estimate of $-0.21.

Revenue was up $1.68 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 2.69% drop in the share price the next day.

To track all earnings releases for Fennec Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FENC Logo
FENCFennec Pharmaceuticals Inc
$5.444.41%

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score
Edge Rankings
Momentum
32.71
Growth
-
Quality
-
Value
20.07
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Posted In: